| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial
|
Curran, Emily
|
|
|
57 |
3 |
p. 101
|
artikel
|
| 2 |
Improving CAR T-cells: The next generation
|
Marple, Andrew H.
|
|
|
57 |
3 |
p. 115-121
|
artikel
|
| 3 |
Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurement
|
Bartram, Jack
|
|
|
57 |
3 |
p. 142-148
|
artikel
|
| 4 |
New approaches to the treatment of older adults with acute lymphoblastic leukemia
|
Schwartz, Marc
|
|
|
57 |
3 |
p. 122-129
|
artikel
|
| 5 |
Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020
|
Rank, Cecilie Utke
|
|
|
57 |
3 |
p. 102-114
|
artikel
|
| 6 |
outside front cover, PMS 8883 metallic AND 4/C
|
|
|
|
57 |
3 |
p. CO1
|
artikel
|
| 7 |
Pharmacogenomics and ALL treatment: How to optimize therapy
|
Karol, Seth E.
|
|
|
57 |
3 |
p. 130-136
|
artikel
|
| 8 |
Philadelphia chromosome positive acute lymphoblastic leukemia in adults: Therapeutic options and dilemmas in 2020
|
Muffly, Lori
|
|
|
57 |
3 |
p. 137-141
|
artikel
|
| 9 |
Role of blinatumomab, inotuzumab, and CAR T-cells: Which to choose and how to sequence for patients with relapsed disease
|
Curran, Emily
|
|
|
57 |
3 |
p. 157-163
|
artikel
|
| 10 |
The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis
|
O'Dwyer, Kristen M.
|
|
|
57 |
3 |
p. 149-156
|
artikel
|
Tijdschrift beschrijving